| Antibiotic Development: HHS Not Yet Sold on “Pull” Incentives | Sarah Karlin-Smith | 05/16/20 | National |
| Drug Review Times Not Shortened Much by Single Expedited Review Designation | Derrick Gingery | 04/24/20 | National |
| Bunker, Startup That Helps Insure Gig Workers, Nabs Cash from Chubb | Jeff Buchanan | 03/29/18 | San Francisco |
| Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More | Frank Vinluan | 12/22/17 | National |
| Gig Economy Growing in Wisconsin, Despite Early Pushback | Jeff Buchanan | 05/31/17 | Wisconsin |
| Cashing in On Duchenne Approval, Sarepta Sells Voucher to Gilead For $125M | Ben Fidler | 02/21/17 | Boston |
| On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data | Ben Fidler | 11/01/16 | National |
| Remove the Cap on Social Security | Carl Weissman | 08/14/12 | Seattle |
| Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again | Luke Timmerman | 03/21/11 | National |
| The Myth of the “Patent Cliff” | Stewart Lyman | 11/29/10 | National |
| The Challenge of Understanding Biotech: Sifting Through the Fog and Jargon | Stewart Lyman | 10/20/10 | Seattle |
| Daily TIPs: Spin Detector, Science Advice, Designer Pigs, & More | Neil Savage | 09/18/08 | National |
| Daily TIPs: Porn Decline, Powdered Gas, Open Arms, & More | Neil Savage | 09/17/08 | National |
